for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Switzerland's Lonza to boost production for Moderna COVID-19 vaccine

ZURICH, April 29 (Reuters) - Contract drug manufacturer Lonza plans to double Swiss production capacity for Moderna’s COVID-19 vaccine, helping the U.S. drugmaker boost total output to as many as 3 billion doses in 2022. (Reporting by John Miller Editing by Riham Alkousaa)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up